Algen Bio
Biotechnology company focused on therapeutic drug discovery through proprietary CRISPR gene-modulation and AI, originating from the UC Berkeley laboratory of Nobel Laureate Professor Jennifer Doudna.
About Algen Bio
Biotechnology company focused on therapeutic drug discovery through proprietary CRISPR gene-modulation and AI, originating from the UC Berkeley laboratory of Nobel Laureate Professor Jennifer Doudna.
Products
Proprietary AI platform using deep learning models built on billions of dynamic gene expression changes throughout disease progression to map causal disease trajectories and rev...
Proprietary, next-generation CRISPR gene-modulation system offering robust, fine-tuned, and precise gene modulation to deconvolute complex biology.
Security and compliance
No security details published yet
Algen Bio hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Algen Bio